Form 4 for ALXO ALX ONCOLOGY HOLDINGS INC
Accepted 2026-08-18 17:50:21 ET · period of report 2026-08-17 · accession 0001193125-26-355761 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 17:50 | 2026-08-17 | ALXO | Wong Shelly | SVP, Fin AND CAO | S - Sale | $1.93 | -573 | 87.8K | -0.6% | -$1,106 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-17 | S | D | 573 | $1.93 | 87,828 | D | — | — | (F1) The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units. |